RKDA Valuation

Arcadia Biosciences Inc

Add to Watchlist

Advanced Chart

4.650

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

RKDA Relative Valuation

RKDA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RKDA is overvalued; if below, it's undervalued.

Historical Valuation

Arcadia Biosciences Inc (RKDA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.89 is considered Fairly compared with the five-year average of -1.78. The fair price of Arcadia Biosciences Inc (RKDA) is between 1.62 to 16.92 according to relative valuation methord.

Relative Value

Fair Zone

1.62-16.92

Current Price：4.65

Fair

-1.71

Trailing

Forward

-1.03

EV/EBITDA

Arcadia Biosciences Inc. (RKDA) has a current EV/EBITDA of -1.03. The 5-year average EV/EBITDA is 0.08. The thresholds are as follows: Strongly Undervalued below -2.12, Undervalued between -2.12 and -1.02, Fairly Valued between 1.19 and -1.02, Overvalued between 1.19 and 2.29, and Strongly Overvalued above 2.29. The current Forward EV/EBITDA of -1.03 falls within the Undervalued range.

-1.03

EV/EBIT

Arcadia Biosciences Inc. (RKDA) has a current EV/EBIT of -1.03. The 5-year average EV/EBIT is 0.22. The thresholds are as follows: Strongly Undervalued below -2.47, Undervalued between -2.47 and -1.12, Fairly Valued between 1.57 and -1.12, Overvalued between 1.57 and 2.92, and Strongly Overvalued above 2.92. The current Forward EV/EBIT of -1.03 falls within the Historic Trend Line -Fairly Valued range.

0.89

Arcadia Biosciences Inc. (RKDA) has a current PS of 0.89. The 5-year average PS is 1.83. The thresholds are as follows: Strongly Undervalued below -1.81, Undervalued between -1.81 and 0.01, Fairly Valued between 3.66 and 0.01, Overvalued between 3.66 and 5.48, and Strongly Overvalued above 5.48. The current Forward PS of 0.89 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Arcadia Biosciences Inc. (RKDA) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Arcadia Biosciences Inc. (RKDA) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.84. The thresholds are as follows: Strongly Undervalued below -3.62, Undervalued between -3.62 and -2.23, Fairly Valued between 0.55 and -2.23, Overvalued between 0.55 and 1.94, and Strongly Overvalued above 1.94. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Arcadia Biosciences Inc (RKDA) has a current Price-to-Book (P/B) ratio of 0.71. Compared to its 3-year average P/B ratio of 0.40 , the current P/B ratio is approximately 79.32% higher. Relative to its 5-year average P/B ratio of 0.80, the current P/B ratio is about -11.24% higher. Arcadia Biosciences Inc (RKDA) has a Forward Free Cash Flow (FCF) yield of approximately -132.98%. Compared to its 3-year average FCF yield of -291.16%, the current FCF yield is approximately -54.33% lower. Relative to its 5-year average FCF yield of -206.14% , the current FCF yield is about -35.49% lower.

0.71

P/B

Median3y

0.40

Median5y

0.80

-132.98

FCF Yield

Median3y

-291.16

Median5y

-206.14

Competitors Valuation Multiple

The average P/S ratio for RKDA's competitors is 1.29, providing a benchmark for relative valuation. Arcadia Biosciences Inc Corp (RKDA) exhibits a P/S ratio of 0.89, which is -31.44% above the industry average. Given its robust revenue growth of 11.41%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

RKDA.O

Arcadia Biosciences Inc

Snow Lake Resources Ltd

Loss

30.82M

AVD.N

American Vanguard Corp

Bioceres Crop Solutions Corp

0.47

-29.09%

185.00M

Performance Decomposition

Market capitalization of RKDA increased by 49.66% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -1.81 to -8.23.

The secondary factor is the Revenue Growth, contributed 11.41%to the performance.

Overall, the performance of RKDA in the past 1 year is driven by P/E Change. Which is more unsustainable.

11.41%

1.31M → 1.46M

Revenue Growth

-316.30%

141.65 → -306.39

Margin Expansion

354.55%

-1.81 → -8.23

P/E Change

49.66%